A University of Kansas study of rare gene mutations that cause hereditary Alzheimer's disease shows these mutations disrupt production of a small sticky protein called amyloid.
Research identifies the human transferrin receptor as an alternative pathway for SARS-CoV-2 infection, offering potential new targets for COVID-19 therapies.
Biotechnology company Nuritas began its AI journey not in a laboratory but in the wild with wallabies. Nora Khaldi, Nuritas founder and CEO, found inspiration from the unlikely source, observing that wallabies have two types of milk with different kinds of peptides that their offspring consume. When the wrong mother’s milk is fed to a wallaby offspring at the wrong time, it doesn’t grow.
Boston College Assistant Professor of Biology Emrah Altindis has been awarded a five-year, $2.5-million grant from the National Institutes of Health to study viral insulins and mechanisms related to IGF-1 receptor protein inhibition and its potential applications in cancer treatment.